Sprint Bioscience AB (publ) (FRA:5JA1)
Germany flag Germany · Delayed Price · Currency is EUR
0.1175
-0.0020 (-1.67%)
At close: Jan 22, 2026

Sprint Bioscience AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
10.9525.0649.9329.4970.6427.08
Cash & Short-Term Investments
10.9525.0649.9329.4970.6427.08
Cash Growth
-65.48%-49.82%69.31%-58.25%160.92%223.09%
Accounts Receivable
--0.80.010.021.33
Other Receivables
6.4512.197.145.385.283.06
Receivables
6.4512.197.945.395.294.39
Prepaid Expenses
-----0.81
Total Current Assets
17.437.2457.8734.8875.9432.27
Property, Plant & Equipment
3.944.724.382.372.990.87
Long-Term Investments
0.050.050.050.050.050.05
Other Long-Term Assets
0.050.050.080.120.160.2
Total Assets
21.4442.0662.3837.4279.1433.4
Accounts Payable
3.35.445.713.732.923.4
Accrued Expenses
-4.73.374.434.547.52
Short-Term Debt
-----10
Current Unearned Revenue
-11.2312.32---
Other Current Liabilities
12.0711.4213.211.071.223.33
Total Current Liabilities
15.3732.7834.69.238.6824.26
Total Liabilities
15.3732.7834.69.238.6824.26
Common Stock
7.076.986.986.983.982.12
Additional Paid-In Capital
291.81273.67273.9273.87258.97174.44
Retained Earnings
-292.82-271.38-253.1-252.67-192.5-167.41
Shareholders' Equity
6.069.2727.7728.1970.459.14
Total Liabilities & Equity
21.4442.0662.3837.4279.1433.4
Total Debt
-----10
Net Cash (Debt)
10.9525.0649.9329.4970.6417.08
Net Cash Growth
-65.48%-49.82%69.31%-58.25%313.73%103.76%
Net Cash Per Share
0.130.360.720.702.451.02
Filing Date Shares Outstanding
105.5269.8269.8269.839.8421.21
Total Common Shares Outstanding
105.5269.8269.8269.839.8421.21
Working Capital
2.034.4623.2725.6567.258.02
Book Value Per Share
0.060.130.400.401.770.43
Tangible Book Value
6.069.2727.7728.1970.459.14
Tangible Book Value Per Share
0.060.130.400.401.770.43
Machinery
-10.969.667.217.214.5
Source: S&P Global Market Intelligence. Standard template. Financial Sources.